A composition has an enzyme that is able to convert a substrate to release hydrogen peroxide; a substrate for the enzyme; and a superabsorbent component, such as a superabsorbent polymer. The composition is in the form of a powder and may form a gel on contact with water.

A sponge assembly including at least some of a pipette having a pipette bulb portion including a hollow interior bulb portion and an elongate pipette body portion including a hollow interior body portion, wherein the pipette extends from the pipette bulb portion to the pipette body portion, wherein the pipette body portion extends from the pipette bulb portion to an open terminal end having an aperture, wherein the aperture of the pipette terminal end allows fluid communication between the open pipette terminal end, the hollow interior body portion, and the hollow interior bulb portion; a sponge support defining an at least partial cavity, wherein the open pipette terminal end is in fluid communication with the sponge support cavity, via the pipette aperture; and at least one sponge portion attached or coupled to the sponge support to cover at least a portion of the at least partial cavity.

A sponge assembly including at least some of a pipette having a pipette bulb portion including a hollow interior bulb portion and an elongate pipette body portion including a hollow interior body portion, wherein the pipette extends from the pipette bulb portion to the pipette body portion, wherein the pipette body portion extends from the pipette bulb portion to an open terminal end having an aperture, wherein the aperture of the pipette terminal end allows fluid communication between the open pipette terminal end, the hollow interior body portion, and the hollow interior bulb portion; a sponge support defining an at least partial cavity, wherein the open pipette terminal end is in fluid communication with the sponge support cavity, via the pipette aperture; and at least one sponge portion attached or coupled to the sponge support to cover at least a portion of the at least partial cavity.

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

The present disclosure provides amine-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include a covalently attached molecule comprising free amine groups. Such amine groups can be used, for instance, to conjugate biologically active polypeptides and/or linkers. Methods for using modified polymers are also provided.

The present disclosure provides amine-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include a covalently attached molecule comprising free amine groups. Such amine groups can be used, for instance, to conjugate biologically active polypeptides and/or linkers. Methods for using modified polymers are also provided.

A method of sealing a durotomy from which cerebrospinal fluid is leaking. A durotomy sealant dressing is prepared by applying an active agent to a dextran base. The durotomy sealant dressing is applied to a durotomy. At least a portion of the durotomy sealant dressing dissolves. The durotomy is sealed with the dissolved durotomy sealant dressing to substantially prevent cerebrospinal fluid from flowing through the durotomy.

A method of sealing a durotomy from which cerebrospinal fluid is leaking. A durotomy sealant dressing is prepared by applying an active agent to a dextran base. The durotomy sealant dressing is applied to a durotomy. At least a portion of the durotomy sealant dressing dissolves. The durotomy is sealed with the dissolved durotomy sealant dressing to substantially prevent cerebrospinal fluid from flowing through the durotomy.

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.